ginkgo (Ginkgo biloba)

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• ADHD [Insufficient Evidence]
• age-related macular degeneration [Insufficient Evidence]
• aging [Insufficient Evidence]
• allergic rhinitis [Insufficient Evidence]
• altitude sickness prevention [Insufficient Evidence]
• angina [Insufficient Evidence]
• anxiety [Possibly Effective]
• asthma [Insufficient Evidence]
• autism spectrum disorder [Insufficient Evidence]
• bronchitis [Insufficient Evidence]
• cancer prevention, ovarian [Insufficient Evidence]
• cardiovascular dz prevention [Possibly Ineffective]
• chronic fatigue syndrome [Insufficient Evidence]
• CKD [Insufficient Evidence]
• cocaine dependence [Insufficient Evidence]
• cognitive decline, age-related [Possibly Ineffective]
• cognitive function [Insufficient Evidence]
• cognitive impairment [Insufficient Evidence]
• cognitive impairment, chemo-related [Possibly Ineffective]
• colorectal CA [Insufficient Evidence]
• COPD [Insufficient Evidence]
• cough [Insufficient Evidence]
• dementia [Possibly Effective]
• depression [Insufficient Evidence]
• diabetes mellitus, type 2 [Insufficient Evidence]
• diabetic retinopathy [Insufficient Evidence]
• dry eye dz [Insufficient Evidence]
• dyslexia [Insufficient Evidence]
• fibromyalgia [Insufficient Evidence]
• gastric CA [Insufficient Evidence]
• glaucoma [Insufficient Evidence]
• hearing loss [Possibly Effective]
• hemorrhoids [Insufficient Evidence]
• HTN [Possibly Ineffective]
• HTN, pulmonary [Insufficient Evidence]
• hypercholesterolemia [Insufficient Evidence]
• intestinal parasite infection [Insufficient Evidence]
• Lyme dz [Insufficient Evidence]
• migraine prophylaxis [Insufficient Evidence]
• multiple sclerosis [Possibly Ineffective]
• pancreatic CA [Insufficient Evidence]
• Parkinson dz [Insufficient Evidence]
• peripheral arterial dz [Insufficient Evidence]
• premenstrual syndrome [Possibly Effective]
• quality of life [Insufficient Evidence]
• radiation dermatitis [Insufficient Evidence]
• radiation exposure [Insufficient Evidence]
• Raynaud phenomenon [Insufficient Evidence]
• scabies [Insufficient Evidence]
• schizophrenia [Possibly Effective]
• seasonal affective disorder [Insufficient Evidence]
• sexual dysfxn [Insufficient Evidence]
• sexual dysfxn, antidepressant-induced [Possibly Ineffective]
• stroke [Possibly Effective]
• tardive dyskinesia [Possibly Effective]
• tinnitus [Possibly Ineffective]
• vascular dementia [Possibly Effective]
• venous thromboembolism [Insufficient Evidence]
• vertigo [Possibly Effective]
• vitiligo [Insufficient Evidence]
• wound healing [Insufficient Evidence]